Vindhya Vatsyayan
Biographic Data
| ID | 9066927 |
|---|---|
| NAME | Vindhya Vatsyayan |
| GIVEN NAMES | Vindhya |
| FAMILY NAME | Vatsyayan |
| SIGNATURE | VATSYAYAN V |
| AFFILIATIONS | Clinton Foundation |
| ORCID | 0009-0009-2655-8743 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
“Dost” Model to Link and Support Drug Resistant TB Patients From Private Sector
Background: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A "DOST" intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care c…
No prominent works on this page.
“Dost” Model to Link and Support Drug Resistant TB Patients From Private Sector
Background: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A "DOST" intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care c…
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Adverse effect (1 work) · Diverse Scientific Research Studies (1 work) · Drug reaction (1 work) · Drug-Induced Adverse Reactions (1 work) · Economic growth (1 work) · Epidemiology (1 work) · Family medicine (1 work) · Healthcare Facilities Design and Sustainability (1 work)